Pricing Log in Create free account

Enovis Corporation (ENOV) vs NovoCure Limited (NVCR)

Enovis Corporation and NovoCure Limited are both Medical Devices companies. Enovis Corporation and NovoCure Limited are of similar size ($1.7B and $1.6B). NovoCure Limited grew revenue faster over the last twelve months: 12.9% against 3.28%. NovoCure Limited has the higher net margin (−16.8% vs −22.9%) and the lower return on invested capital (−106.1% vs −10.8%). Across the 18 metrics below, NovoCure Limited leads on 10 and Enovis Corporation on 8.

Valuation

Metric ENOV NVCR Medical Devices median
P/E n/m n/m 25.58
P/S 0.72 2.18 2.54
P/B 1.11 4.51 2.48
Price to free cash flow 23.80 n/m 28.81
EV/EBITDA 9.39 n/m 11.51
EV/Sales 1.26 1.80 2.72
Earnings yield (32.54%) (7.83%) (12.82%)
Free cash flow yield 4.20% (1.56%) (8.18%)

Profitability

Metric ENOV NVCR Medical Devices median
Gross margin 61.31% 77.02% 57.76%
Operating margin (20.59%) (17.17%) (15.07%)
Net margin (22.87%) (16.78%) (14.45%)
Free cash flow margin 3.02% (3.39%) (3.88%)
Return on equity (29.97%) (35.18%) (10.35%)
Return on assets (12.91%) (11.12%) (17.26%)
Return on invested capital (10.83%) (106.10%) (5.27%)

Growth

Metric ENOV NVCR Medical Devices median
Revenue growth (TTM) 3.28% 12.94% 10.41%
EPS growth (last fiscal year) (38.98%) 21.79% 28.17%
Revenue growth, 5-year CAGR 14.94% 5.80% 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENOV NVCR Medical Devices median
Debt to equity 0.84 0.56 0.04
Current ratio 2.15 2.49 2.74
Net debt to EBITDA 5.73 1.36 0.54

Dividend

Metric ENOV NVCR Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric ENOV NVCR Medical Devices median
Market cap 1.65b 1.58b 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack